CRISPR genome editing allows scientists to alter the genome of any organism. This technology is moving towards therapeutic research applications and has been tested in cell and gene therapy in clinical trials. Amplicon sequencing can be used to quickly characterize the full array of on- and off-target genome editing events. The rhAmpSeq™ system is a multiplexed, PCR-based targeted next generation sequencing approach that can accurately quantify editing efficiency.
Join IDT as we host this webinar to learn how researchers are using both technologies.
Thursday, August 13
9:00 am–10:00 am CST